Spotlight
Memorials
Classifieds
Families First
VCAs
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Program
New on WRAL at 11: A look at reactions from local government officials ahead of the anticipated immigration crackdown in Raleigh.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Waldencast plc
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
November 16, 2025
From
Waldencast plc
Via
GlobeNewswire
Tickers
WALD
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities
November 14, 2025
From
Waldencast plc
Via
GlobeNewswire
Tickers
WALD
Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates
November 12, 2025
From
Waldencast plc
Via
GlobeNewswire
Tickers
WALD
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
October 08, 2025
From
Waldencast plc
Via
GlobeNewswire
Tickers
WALD
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
September 10, 2025
From
Waldencast plc
Via
GlobeNewswire
Tickers
WALD
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
August 18, 2025
From
Waldencast plc
Via
GlobeNewswire
Tickers
WALD
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
July 23, 2025
From
Waldencast plc
Via
GlobeNewswire
Tickers
WALD
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.